Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in mycobacterial research.

A J Steyn1, J Chan, V Mehra

  • 1Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, Massachusetts, USA.

Current Opinion in Infectious Diseases
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dosimetric comparison of intensity modulated proton therapy and knowledge-based volumetric arc therapy for left-sided breast cancer.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2026
Same author

A systematic review of the use of corticosteroid injections with and without local anaesthetic for trigger finger.

Acta chirurgiae plasticae·2026
Same author

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Reply.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same journal

Use of gloves: current evidence vs. current use.

Current opinion in infectious diseases·2026
Same journal

Understanding challenges to prevention of healthcare related infections.

Current opinion in infectious diseases·2026
Same journal

Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.

Current opinion in infectious diseases·2026
Same journal

Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients.

Current opinion in infectious diseases·2026
Same journal

Dengue and chikungunya vaccines past, present and future: implications for travelers.

Current opinion in infectious diseases·2026
Same journal

Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

Current opinion in infectious diseases·2026
See all related articles

Tuberculosis (TB) poses a global health threat, especially for AIDS patients. Advances in mycobacterial genomics offer new avenues for developing novel TB drugs and vaccines.

Area of Science:

  • Genomics
  • Mycobacterial Genetics
  • Infectious Diseases

Background:

  • Tuberculosis (TB) is a significant global health challenge.
  • High rates of Mycobacterium tuberculosis infections occur in AIDS patients.
  • Urgent need for new TB drugs and interventions.

Purpose of the Study:

  • To review recent advancements in understanding Mycobacterium tuberculosis.
  • To highlight progress in mycobacterial genomics and genetics.
  • To discuss novel vaccine strategies and tuberculous dormancy.

Main Methods:

  • Genomic sequencing of M. tuberculosis.
  • Analysis of mycobacterial genetic research.
  • Review of current TB research literature.

Related Experiment Videos

Main Results:

  • Complete genome sequence of M. tuberculosis provides a foundation for drug design.
  • Genomic data facilitates the development of new chemotherapeutic and immunotherapeutic interventions.
  • Insights into tuberculous dormancy are emerging.

Conclusions:

  • Mycobacterial genomics is crucial for advancing TB treatment and prevention.
  • Understanding TB genetics is key to overcoming drug resistance and improving outcomes.
  • Novel vaccine strategies and dormancy research hold promise for TB control.